[afro-nets] Pharmaceutical Pricing Policies in a Global Market

Cross posted from: EQUIDAD@listserv.paho.org

Pharmaceutical Pricing Policies in a Global Market

OECD Health Policy Studies - Directorate for Employment, Labour and Social Affairs, Health Division
September 2008

Pharmaceutical pricing policies are designed with national objectives in mind, but are the transnational implications always taken into account?

Executive summary: http://www.oecd.org/dataoecd/36/2/41303903.pdf

OECD website:
http://www.oecd.org/document/36/0,3343,en_2649_33929_41000996_1_1_1_37407,00.html

"….This report assesses how pharmaceutical pricing and reimbursement policies have contributed to the achievement of certain health policy objectives. It examines the national and transnational effects of these policies, in particular, their implications for the availability of medicines in other countries, the prices of these medicines, and innovation in the pharmaceutical sector.

This publication presents an analysis of comparative price levels, making use of a unique dataset to construct the most comprehensive pan-OECD pharmaceutical price index to date. It also draws upon original case studies of pharmaceutical pricing and reimbursement policies in six OECD countries to provide specific examples of the impacts of policies on health system performance The latest comparable data and trends on different aspects of the performance of health systems in OECD countries…."

Table of Contents

Executive Summary

Introduction

Chapter 1. Key Characteristics of the Pharmaceutical Sector in OECD Economies

Chapter 2. The Pharmaceutical Industry and its Activities

Chapter 3. Pharmaceutical Pricing and Reimbursement and the Broader Pharmaceutical Policy

Chapter 4. The Impact of Pharmaceutical Pricing Policies on Performance in Meeting Health Policy Goals

Chapter 5. The Impact of National Pricing and Reimbursement Practices on Prices and Availability of Medicines in Other Countries

Chapter 6. The Impact of Pharmaceutical Pricing Policies on Pharmaceutical Innovation

--
Ruggiero, Mrs. Ana Lucia (WDC)
mailto:ruglucia@paho.org